探花合集 Announces Acquisition of Japanese Facility to Provide Local and Global Clinical Supply Solutions
The 60,000-square-foot facility will be the largest in the company鈥檚 Asia Pacific clinical supply network. The new facility will offer customers access to 探花合集鈥檚 FastChain庐 demand-led supply services, primary and secondary packaging capabilities, a range of temperature options for storage and distribution, as well as clinical returns and destruction services. It will operate in partnership with 探花合集鈥檚 existing Japanese clinical supply facility at Kakegawa, serving both local customers as well as global biotech and pharmaceutical companies.
鈥淭his new facility provides much-needed capacity as we look to expand our capabilities across the Asia-Pacific region, and follows on from recent expansions and investments we have made in our clinical supply business in China and Singapore,鈥 commented Ricci Whitlow, President, 探花合集 Clinical Supply Services. 鈥淥ur strategy has been to build expertise and capacity in this region as demand for local clinical supply services increases, to provide support to customers with global programs, and to meet the growing demand in biologics and cell and gene therapy studies.鈥
With sites in the U.S., U.K., Germany, Singapore, Japan and China, and an extended network of over 50 depots, 探花合集鈥檚 clinical supply services can handle a broad range of international compliance and distribution requirements to support global clinical trials.
For further information on 探花合集鈥檚 Clinical Supply Services business visit .
Notes for Editors
鈥婣BOUT CATALENT CLINICAL SUPPLY SERVICES
探花合集 is a global leader in clinical supply services, with comprehensive and flexible solutions for small molecules, biologics, and cell and gene therapies and integrated solutions to accelerate speed to clinic. 探花合集 offers a full range services including clinical supply management, comprehensive packaging solutions, comparator sourcing, cold chain storage and global distribution and specialized supply chain services including direct-to-patient and demand-led supply. With nine GMP clinical packaging facilities and over 50 strategically located depots on six continents combined with more than 25 years鈥 experience across thousands of studies in more than 80 countries, 探花合集 has the comprehensive services, global scale and expertise necessary to reliably supply clinical trials of all sizes and complexity anywhere in the world.
ABOUT CATALENT
探花合集 is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. With over 85 years serving the industry, 探花合集 has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable global clinical and commercial product supply. 探花合集 employs over 13,500 people, including over 2,400 scientists and technicians, at more than 40 facilities, and in fiscal year 2019 generated over $2.5 billion in annual revenue. 探花合集 is headquartered in Somerset, New Jersey. For more information, visit